期刊文献+

siRNA沉默葡萄糖调节蛋白78可增强乳腺癌细胞对顺铂的敏感性 被引量:4

Small interfering RNA-mediated glucose-regulated protein 78 knockdown enhances chemosensitivity of breast cancer cells to cisplatin
下载PDF
导出
摘要 目的探讨siRNA沉默葡萄糖调节蛋白78(GRP78)增强顺铂对乳腺癌细胞凋亡的敏感性,以期为乳腺癌的临床治疗提供新的靶点。方法 MTT法检测不同浓度(0、1、2、4、8、16μmol/L)顺铂对乳腺癌细胞MDA-MB-231的增殖抑制作用;PI/AnnexinV双染检测顺铂(8μmol/L)对siRNA转染沉默GRP78乳腺癌细胞MDA-MB-231凋亡的影响,同时将未转染和转染空质粒乳腺癌细胞MDA-MB-231作为空白和阴性对照;Western blot检测顺铂(8μmol/L)处理乳腺癌细胞MDA-MB-231不同时间(0、6、16、24 h)GRP78的表达以及siRNA转染沉默GRP78乳腺癌细胞MDA-MB-231中GRP78的表达。结果 8μmol/L顺铂作用于乳腺癌细胞MDA-MB-231 24、48、72 h细胞存活率分别为83.13%、54.22%、35.79%,但24 h细胞凋亡率仅为10.8%。将GRP78沉默后,细胞的凋亡率为24.6%,沉默GRP78并合用顺铂进行刺激,细胞的凋亡率为48.9%,明显高于单用顺铂组。用顺铂刺激乳腺癌细胞MDA-MB-231 GRP78表达先上调后有减弱趋势,而siRNA转染沉默GRP78后,GRP78表达明显下降。结论抑制GRP78的表达可以增加乳腺癌细胞的凋亡率,为乳腺癌的临床治疗提供了新的靶点。 Objective To investigate the effect of small interfering RNA-mediated glucose-regulated protein 78 (GRP78) knockdown on the chemosensitivity of breast cancer cells to cisplatin. Methods Human breast cancer cell line MDA-MB-231 was exposed to different doses of cisplatin (0, 1, 2, 4, 8, and 16 pmol/L), and the changes in cell viability were detected using MTT assay. PI/Annexin V staining was used to observe the apoptosis of the cells in response to transfection with a small interfering RNA targeting GRP78 (pSHISi-GRP78). Western blotting was employed to detect GRP78 expression in pSHISi- GRP78-transfected cells after exposure to 8 pmol/L cisplatin for 24, 48 and 72 h. Results Exposure of the cells to 8 pmol/L cisplatin for 24, 48 and 72 h resulted in a cell survival rate of 83.13%, 54.22% and 35.79%, respectively, but the cell apoptosis rate was only 10.8% at 24 h. Transfection of MDA-MB-231 cells with pSHISi-GRP78 caused a cell apoptosis rate of 24.6%, which increased to 48.9% in cells with both pSH1Si-GRP78 transfection and cisplatin exposure. Cisplatin exposure caused an initial up-regulation followed then by a down-regulation of GRP78 expression in MDA-MB-231 cells, while pSHISi-GRP78 transfection produced an obvious down-regulation of GRP78 expression. Conclusions Inhibition of GRP78 expression increases the apoptosis and enhance cisplatin chemosensitivity of breast cancer cells in vitro, suggesting the value of GRP78 as a potential therapeutic target in the clinical treatment of breast cancer.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第1期44-47,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81000992 81072207) 安徽省教育厅自然科学研究重点项目(KJ2012A201) 安徽省自然科学基金(1208085MH136)~~
关键词 乳腺癌 葡萄糖调节蛋白78 小干扰RNA 顺铂 凋亡 breast cancer glucose-regulated protein 78 small interfering RNA cisplatin apoptosis
  • 相关文献

参考文献15

  • 1Mandala M, C Tondini. Adjuvant therapy in breast cancer andvenous thromboembolism[J].Thromb Res, 2012, 130(1): 66-70. 被引量:1
  • 2Li ZF, Wang SM, Shi JF, ct al. Combined screening of cervicalcanccr, breast canccr and reproductive tract infections in rural china[J]. Asian Pac J Cancer Prcv, 2012, 13(7): 3529-33. 被引量:1
  • 3stillo CS, Hikima JI, Jang HB, et al. Comparative sequenceanalysis of a multi-drug resistant plasmid from Acromonashydrophila [J]. Antimicrob Agents Chemother, 2012, 125(30):654-50. 被引量:1
  • 4Burguillos MA, Hajji N, Englund E, et al. Apoptosis-inducing factormediates dopaminergic cell death in response to LPS-inducedinflammatory stimulus: evidence in Parkinson's disease paticnts[j].Neurobiol Dis, 2010,41(1): 177-88. 被引量:1
  • 5Delie F, P Petignat, M Cohen. GRP78 Protein expression in ovariancancer patients and perspectives for a daig-targeting approach[J]. JOncol, 2012, 20(12): 615-9. 被引量:1
  • 6Guy GP, Jr LC, Richardson. Visit duration for outpatient physicianoffice visits among patients with cancer[j]. J Oncol Pract, 2012, 8(3): 112-8. 被引量:1
  • 7Hung JY, Hsu Y L, Ko YC, et al. Didymin, a dietary flavonoidglycoside from citrus fruits, induces Fas-mediated apoptoticpathway in human non-small-cell lung cancer cells in vitro and invivo[J]. Lung Cancer, 2010, 68(3): 366-74. 被引量:1
  • 8Coelho AG, Zamarioli LA, Telles MA, et al. A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, SaoPaulo, Brazil[J]. Mem Inst Oswaldo Cruz, 2012, 107(6): 760-6. 被引量:1
  • 9Schindlbeck C, Mayr D, Olivier C, et al. Topoisomcrase II alphaexpression rather than gene amplification predicts responsivenessof adjuvant anthracycline-based chemotherapy in women withprimary breast cancer[j], J Cancer Res Clin Oncol, 2010, 136(7):1029-37. 被引量:1
  • 10Hasty AH, DG Harrison. Endoplasmic reticulum stress and hy-pertension-a new paradigm[J].J Clin Invest, 2012, 25( 13): 205-8. 被引量:1

同被引文献91

  • 1孟亚,张晓雯,刘玉国.姜黄素通过调控miR-7641/PTPN14分子轴抑制乳腺癌发展进程的分子机制研究[J].药物评价研究,2020,0(1):42-51. 被引量:5
  • 2马涛,张君莹,吴建中,唐金海.miR-342-3p对三阴性乳腺癌化疗敏感性的影响[J].中南大学学报(医学版),2014,39(5):488-495. 被引量:8
  • 3Gething MJ. Role and regulation of the ER chaperone BiP. Semin Cell Dev Biol, 1999, 10:465-472. 被引量:1
  • 4Fu Y, Li J, Lee AS. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen-starvation induced apoptosis. Cancer Res, 2007, 67:3734-3740. 被引量:1
  • 5Cook KL, Shajahan AN, Wrri A, et al. Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Res, 2012, 72:3337-3349. 被引量:1
  • 6Li J, Ni M, Lee B, et al. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress induced autophagy in mammalian cells. Cell Death Differ, 2008, 15: 1460- 1471. 被引量:1
  • 7Luo S, Mao C, Lee B, et al. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol Cell Biol, 2006, 26:5688-5697. 被引量:1
  • 8Pyrko P, Sch6nthal AH, Hofman FM, et al. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res, 2007, 67:9809-9816. 被引量:1
  • 9Zhang Y, Liu R, Ni M, et al. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. J Biol Chem, 2010, 285:15065-15075. 被引量:1
  • 10Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signaling and therapeutic targeting. Biochem J, 2011, 434:181-188. 被引量:1

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部